ATE403743T1 - Genetische veränderungen, die mit lungencarzinomen korrelieren - Google Patents

Genetische veränderungen, die mit lungencarzinomen korrelieren

Info

Publication number
ATE403743T1
ATE403743T1 AT95907377T AT95907377T ATE403743T1 AT E403743 T1 ATE403743 T1 AT E403743T1 AT 95907377 T AT95907377 T AT 95907377T AT 95907377 T AT95907377 T AT 95907377T AT E403743 T1 ATE403743 T1 AT E403743T1
Authority
AT
Austria
Prior art keywords
correlate
lung carcinoma
genetic changes
lung cancer
correlated
Prior art date
Application number
AT95907377T
Other languages
English (en)
Inventor
Michael F Christman
Joe W Gray
Nikki A Levin
Pius Brzoska
Haruhiko Nakamura
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE403743T1 publication Critical patent/ATE403743T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95907377T 1994-02-22 1995-01-11 Genetische veränderungen, die mit lungencarzinomen korrelieren ATE403743T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/199,772 US5670314A (en) 1994-02-22 1994-02-22 Genetic alterations that correlate with lung carcinomas

Publications (1)

Publication Number Publication Date
ATE403743T1 true ATE403743T1 (de) 2008-08-15

Family

ID=22738963

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907377T ATE403743T1 (de) 1994-02-22 1995-01-11 Genetische veränderungen, die mit lungencarzinomen korrelieren

Country Status (6)

Country Link
US (1) US5670314A (de)
EP (1) EP0757723B1 (de)
AT (1) ATE403743T1 (de)
DE (1) DE69535802D1 (de)
DK (1) DK0757723T3 (de)
WO (1) WO1995022624A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025126A (en) 1991-10-28 2000-02-15 Arch Development Corporation Methods and compositions for the detection of chromosomal aberrations
US7115364B1 (en) 1993-10-26 2006-10-03 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US20060229824A1 (en) * 1993-10-26 2006-10-12 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes
US6309823B1 (en) * 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US5635351A (en) * 1995-03-14 1997-06-03 The Regents Of The University Of California Genetic gain and loss in gliomas
JP2000500329A (ja) * 1995-10-23 2000-01-18 インペリアル キャンサー リサーチ テクノロジィ リミテッド 癌罹病性の診断およびその治療
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US6391550B1 (en) 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
DE69920032T2 (de) * 1998-11-10 2005-09-15 Genset Methoden, software und apparate zur identifizierung genomischer bereiche, die ein gen umfassen, das mit einem nachweisbaren merkmal assoziiert ist
US6232073B1 (en) 1999-02-05 2001-05-15 Virginia Commonwealth University Nucleic acid marker for cancer
AUPQ421699A0 (en) * 1999-11-24 1999-12-16 University Of Western Australia, The Tumour suppressor factor
AU2000258017A1 (en) * 2000-07-17 2002-02-13 Jiahui Xia Human source gene leading sequence, gene vector and gene expression strategy
AU2001281136A1 (en) * 2000-08-04 2002-02-18 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
JP4251437B2 (ja) * 2001-02-20 2009-04-08 バイシス・インコーポレーテツド 癌の検出のための方法およびプローブ
US20050170378A1 (en) * 2004-02-03 2005-08-04 Yakhini Zohar H. Methods and systems for joint analysis of array CGH data and gene expression data
EP1948223A4 (de) * 2005-10-07 2009-10-21 Biopharmica Ltd Sumoylierungskontrollmittel und seine verwendungen
US20090104613A1 (en) * 2005-12-23 2009-04-23 Perkinelmer Las, Inc. Methods and compositions relating to multiplexed genomic gain and loss assays
EP1969337A4 (de) * 2005-12-23 2010-01-27 Perkinelmer Las Inc Multiplex-testverfahren unter verwendung magnetischer und nichtmagnetischer partikel
EP2508622B1 (de) 2005-12-23 2016-09-14 Perkinelmer Las, Inc. Vergleichende genomische Hybridisierung auf codierten Multiplexteilchen
US20100009373A1 (en) * 2005-12-23 2010-01-14 Perkinelmer Health Sciences, Inc. Methods and compositions relating to multiplex genomic gain and loss assays
US7932037B2 (en) * 2007-12-05 2011-04-26 Perkinelmer Health Sciences, Inc. DNA assays using amplicon probes on encoded particles
WO2007075910A2 (en) * 2005-12-23 2007-07-05 Perkinelmer Las, Inc. Methods and compositions for detecting enzymatic activity
FI121236B (fi) * 2006-01-18 2010-08-31 Licentia Oy Menetelmä asbestialtistukseen liittyvien keuhkosyöpien tunnistamiseksi
EP1989329A2 (de) * 2006-01-25 2008-11-12 Board of Regents, The University of Texas System Erkennung und diagnose von durch rauchen bedingten krebserkrankungen
US20100215637A1 (en) * 2006-03-28 2010-08-26 Biopharmica Ltd Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
JP2009532038A (ja) 2006-04-07 2009-09-10 バイオファルミカ リミテッド 転写因子モジュレーター
EP2061906B1 (de) * 2006-09-12 2011-08-31 Genentech, Inc. Verfahren und zusammensetzungen zur diagnose und behandlung von lungenkrebs mittels pdgfra-, kit- oder kdg-gen als genmarker
EP1985713A1 (de) * 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Verfahren und Werkzeuge zur Erkennung des Vorhandenseins kolorektaler Adenokarzinomzellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060267A1 (en) * 1991-02-22 1992-08-23 Joe W. Gray Chromosome specific staining to detect genetic rearrangements

Also Published As

Publication number Publication date
EP0757723A1 (de) 1997-02-12
EP0757723B1 (de) 2008-08-06
EP0757723A4 (de) 1999-09-08
US5670314A (en) 1997-09-23
DE69535802D1 (de) 2008-09-18
WO1995022624A1 (en) 1995-08-24
DK0757723T3 (da) 2008-12-01

Similar Documents

Publication Publication Date Title
EP0757723A4 (de) Genetische veränderungen, die mit lungencarzinomen korrelieren
DE3587427D1 (de) Hybridisierungsverfahren zum nachweis genetischer stoffe.
DE69733958D1 (de) Verfahren zur positionierung von klonen mittels molekularen kaemmens
AU4595996A (en) Discontinuous probe design using hybritope mapping
DE60033555D1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
EP0722508A4 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
NO862918L (no) Analyse for nukleinsyresekvenser, spesielt genetiske lesjoner.
WO1998035693A3 (en) Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
DE69932813D1 (de) Nukleinsäurebindungsproteine
EP1439393A3 (de) Nachweisverfahren TIMP 1 verwendend für Kolonkrebs-Diagnose
DE69609161D1 (de) Amplifikationsoligonukleotide und sonden für borrelia, die mit lyme kranheit assoziiert sind
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
PL1668152T3 (pl) Identyfikacja sygnatury ekspresji genów ERBB2 w rakach sutka
DK1179088T3 (da) Sammensætninger og fremgangsmåder til genetisk analyse
WO1995016919A3 (en) Methods and compositions for the detection of colon cancers
PL327066A1 (en) Method of diagnosing and treating squamous cell carcinomas
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
EP1092783A4 (de) Verfahren zur krebsdiagnose auf basis des nachweises von chromosomenabnormalitäten
EP0747489A3 (de) Nucleinsäuresonden und Amplifizierungsoligonukleotide für Neisseria Spezies
EP1038025A4 (de) Genetische veränderungen im zusammenhang mit krebs
WO1999058971A3 (en) Methods for quantitating low level modifications of nucleotide sequences
SE0103423D0 (sv) Polymorphism
ATE440968T1 (de) Verfahren zur diagnostizierung von aspirinunverträglichkeit
WO2004048548A3 (en) Methods for identifying risk of breast cancer and treatments thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties